Drug intelligence / Profile preview

saccharin

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Saccharin is a non-nutritive artificial sweetener approximately 300–500 times sweeter than sucrose. It is used to sweeten foods and beverages without adding calories and is commonly found in products such as diet drinks, candies, baked goods, pharmaceuticals (as an excipient), vitamins, toothpaste, and mouthwash[1][2][4]. Saccharin is heat-stable and does not react with other food ingredients. The most common forms are its sodium or calcium salts due to their high water solubility[1]. While primarily used as a sugar substitute for people seeking low-calorie options or those with diabetes (since it does not affect blood glucose), recent research has shown that saccharin can disrupt bacterial cell division and biofilm formation by destabilizing bacterial membranes and interfering with DNA replication—suggesting potential antimicrobial properties[6][8]. Saccharin was once linked to cancer risk in animal studies but has since been deemed safe for human consumption by regulatory authorities such as the FDA[7].

Brand names
Sweet'N LowSweet TwinNecta Sweet
Other names
saccharinesaccharin sodiumsaccharin calcium
02

Targets

PGN (Peptidoglycan)

Beyond the preview

Go deeper on saccharin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on saccharin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call